JYNT Stock Overview
Operates and franchises chiropractic clinics in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
The Joint Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$17.22 |
| 52 Week High | US$17.82 |
| 52 Week Low | US$7.31 |
| Beta | 1.58 |
| 1 Month Change | 41.38% |
| 3 Month Change | 67.35% |
| 1 Year Change | 18.84% |
| 3 Year Change | -70.40% |
| 5 Year Change | 4.74% |
| Change since IPO | 161.70% |
Recent News & Updates
Recent updates
Optimistic Investors Push The Joint Corp. (NASDAQ:JYNT) Shares Up 26% But Growth Is Lacking
May 04
The Joint Corp.'s (NASDAQ:JYNT) Share Price Not Quite Adding Up
Mar 10Returns Are Gaining Momentum At Joint (NASDAQ:JYNT)
Feb 12Joint (NASDAQ:JYNT) Shareholders Will Want The ROCE Trajectory To Continue
Jun 17Joint's (NASDAQ:JYNT) Returns On Capital Are Heading Higher
Jan 04Does Joint (NASDAQ:JYNT) Have A Healthy Balance Sheet?
Oct 27The Joint Corp. Can Relieve You From High Inflation Pain
Oct 17The Joint Corp.: Weakening Bottom-Line Fundamentals Unsupportive In Current Landscape
Aug 05These 4 Measures Indicate That Joint (NASDAQ:JYNT) Is Using Debt Reasonably Well
Jul 22Returns Are Gaining Momentum At Joint (NASDAQ:JYNT)
Jun 29Is There Now An Opportunity In The Joint Corp. (NASDAQ:JYNT)?
Jun 14Joint's (NASDAQ:JYNT) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Mar 03Should You Be Adding Joint (NASDAQ:JYNT) To Your Watchlist Today?
Feb 23Does Joint (NASDAQ:JYNT) Have A Healthy Balance Sheet?
Feb 08Joint Corp.: Solid Q4 Results From This Small-Cap Growth Story
Jan 30Joint (NASDAQ:JYNT) Shareholders Will Want The ROCE Trajectory To Continue
Jan 24What Does The Joint Corp.'s (NASDAQ:JYNT) Share Price Indicate?
Jan 08Do Joint's (NASDAQ:JYNT) Earnings Warrant Your Attention?
Nov 23Is Joint (NASDAQ:JYNT) A Risky Investment?
Nov 08Joint (NASDAQ:JYNT) Shareholders Will Want The ROCE Trajectory To Continue
Oct 21Is The Joint Corp. (NASDAQ:JYNT) Potentially Undervalued?
Oct 05The Joint Corporation: Time To Take Some Profits
Aug 10Is Joint (NASDAQ:JYNT) Using Too Much Debt?
Aug 02The Joint Corp. Has Rallied By 400% Since We Bought, But It's Time To Let It Go
Jul 23Returns Are Gaining Momentum At Joint (NASDAQ:JYNT)
Jul 15Do Joint's (NASDAQ:JYNT) Earnings Warrant Your Attention?
Jun 04Shareholder Returns
| JYNT | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 4.7% | 1.5% | 1.8% |
| 1Y | 18.8% | 6.7% | 26.1% |
Return vs Industry: JYNT exceeded the US Healthcare industry which returned 6.7% over the past year.
Return vs Market: JYNT underperformed the US Market which returned 26.1% over the past year.
Price Volatility
| JYNT volatility | |
|---|---|
| JYNT Average Weekly Movement | 13.0% |
| Healthcare Industry Average Movement | 7.0% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in US Market | 16.1% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: JYNT's share price has been volatile over the past 3 months.
Volatility Over Time: JYNT's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 619 | Peter Holt | www.thejoint.com |
The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
The Joint Corp. Fundamentals Summary
| JYNT fundamental statistics | |
|---|---|
| Market cap | US$257.85m |
| Earnings (TTM) | -US$11.13m |
| Revenue (TTM) | US$119.12m |
2.2x
P/S Ratio-23.2x
P/E RatioIs JYNT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| JYNT income statement (TTM) | |
|---|---|
| Revenue | US$119.12m |
| Cost of Revenue | US$10.79m |
| Gross Profit | US$108.33m |
| Other Expenses | US$119.46m |
| Earnings | -US$11.13m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.74 |
| Gross Margin | 90.94% |
| Net Profit Margin | -9.34% |
| Debt/Equity Ratio | 0% |
How did JYNT perform over the long term?
See historical performance and comparison